JZYY(SH:600750) Zheng Quan Zhi Xing·2025-08-21 10:19Core Viewpoint - Jiangzhong Pharmaceutical Co., Ltd. is implementing a buyback and cancellation of certain restricted stocks as part of its 2021 stock incentive plan, which aims to enhance employee motivation and ensure sustainable development [1][5][10]. Summary by Sections Legal Framework - The legal opinion is based on the Company Law, Securities Law, and relevant regulations regarding stock incentive management [2][3]. - The law firm confirms that the company has provided all necessary and truthful documentation for the issuance of this legal opinion [3]. Buyback Authorization - The buyback plan has been approved by the company's board and is in compliance with the relevant legal requirements [4][10]. - The company aims to establish a long-term incentive mechanism to motivate core employees and does not harm the interests of the company or its shareholders [5][10]. Buyback Details - The buyback is due to certain employees no longer meeting the incentive conditions, resulting in the cancellation of 42,733 shares, which is 0.0067% of the total share capital [11]. - The adjusted buyback price is set at 2.0998 yuan per share, based on previous cash dividends [12][13]. - The total amount for the buyback is 89,730.75 yuan, sourced from the company's own funds [12][13]. Conclusion - The legal opinion concludes that the company has fulfilled the necessary legal procedures for the buyback and cancellation of shares, and further actions will be taken in accordance with relevant regulations [13].